Inovio Pharmaceuticals Inc (INO)

[rockcutter]

New Article from NYSE

This guy doesn't have a very good grasp of English . LOL

http://nysepost.com/inovio-pharmaceuticals-inc-nysemktino-create-a-careful-move-5043

Inovio Pharmaceuticals Inc (NYSEMKT:INO) – Create A Careful move
By Kevin Gaddis
1079 Views
Posted In
Health
Tagged as
Inovio Pharmaceuticals Inc (NYSEMKT:INO)NYSEMKT:INO

Boston, MA, 08/08/2013 (nysepost) – There had lately been many mortgage approvals of medication from the Food and Drug Administration of the U.S. Declares in this year, which had shifted on the organizations in the medication industry to obtain successfully in their stocks. One such medication gamer is Inovio Pharmaceuticals Inc. (NYSEMKT:INO), its main concentration is on the growth of new generation vaccinations for illnesses like melanoma and relevant attacks. The organization had been introducing effective outcomes, relevant to the clinical level tests of its vaccinations in the latest several weeks to put it in an ideal place to take off for another increase in discuss costs.
Medical Tests of H7N9 Vaccine
During 30 days of this summer 2013, it was revealed that the H7N9 DNA vaccine component that is currently in medical trials of Inovio Pharmaceuticals Inc. (NYSEMKT:INO) had proved efficient in guaranteeing 100% security of the vaccinated animals from the disease. The outcomes of medical trials presented, that the vaccine designed by Inovio Pharmaceuticals Inc. (NYSEMKT:INO) had not only been effective at producing security in the examined creatures centered on hemagluttination self-consciousness, but had also shown efficient to produce strong T-cell reactions which is important to make sure that there is no increase in the degree of the disease.
Economical status
All such great results relevant to the growth level assessments of the route product candidates had led to a shift of 115% improve in the discus costs for the last 30 days of dealing. However, the financial performance of the medication company had not been extremely eye-catching for the last several years, as Inovio Pharmaceuticals Inc. (NYSEMKT:INO) had exposed nothing, but problems for the last 30 years of business functions. It had been exposed, that the company had created net sales of $3.90 million with problems of $20.30 million for the last 12 several weeks.